期刊文献+

Helicobacter pylori associated gastric intestinal metaplasia:Treatment and surveillance 被引量:23

Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance
下载PDF
导出
摘要 Gastric cancer(GC) is one of the leading causes of cancer related death in the world, particularly in East Asia. According to the Correa's cancer cascade, noncardia GC is usually developed through a series of mucosal changes from non-atrophic gastritis to atrophic gastritis(AG), intestinal metaplasia(IM), dysplasia and adenocarcinoma. Atrophic gastritis and IM are therefore generally considered to be pre-neoplastic gastric lesions. Helicobacter pylori(H. pylori) infection is an important initiating and promoting step of this gastric carcinogenesis cascade. Emerging long-term data showed that eradication of H. pylori reduced the risk of subsequent cancer development. It however remains confusing whether eradication of the bacterium in individuals with pre-neoplastic gastric lesions could regress these changes as well as in preventing cancer. Whilst H. pylori eradication could likely regress AG, the presence of IM may be a point of no return in this cascade. Hence, surveillance by endoscopy may be indicated in those with extensive IM or those with incomplete IM, particularly in populations with high GC risk. The optimal interval and the best tool of surveillance endoscopy remains to be determined in future studies. Gastric cancer(GC) is one of the leading causes of cancer related death in the world, particularly in East Asia. According to the Correa's cancer cascade, noncardia GC is usually developed through a series of mucosal changes from non-atrophic gastritis to atrophic gastritis(AG), intestinal metaplasia(IM), dysplasia and adenocarcinoma. Atrophic gastritis and IM are therefore generally considered to be pre-neoplastic gastric lesions. Helicobacter pylori(H. pylori) infection is an important initiating and promoting step of this gastric carcinogenesis cascade. Emerging long-term data showed that eradication of H. pylori reduced the risk of subsequent cancer development. It however remains confusing whether eradication of the bacterium in individuals with pre-neoplastic gastric lesions could regress these changes as well as in preventing cancer. Whilst H. pylori eradication could likely regress AG, the presence of IM may be a point of no return in this cascade. Hence, surveillance by endoscopy may be indicated in those with extensive IM or those with incomplete IM, particularly in populations with high GC risk. The optimal interval and the best tool of surveillance endoscopy remains to be determined in future studies.
出处 《World Journal of Gastroenterology》 SCIE CAS 2016年第3期1311-1320,共10页 世界胃肠病学杂志(英文版)
关键词 HELICOBACTER PYLORI GASTRIC cancer Intestinalmetaplasia TREATMENT SURVEILLANCE Helicobacter pylori Gastric cancer Intestinal metaplasia Treatment Surveillance
  • 相关文献

二级参考文献11

  • 1KatherineDCrew,AlfredINeugut.Epidemiology of gastric cancer[J].World Journal of Gastroenterology,2006,12(3):354-362. 被引量:186
  • 2S. Koga,N. Kaibara,H. Kishimoto,H. Nishidoi,O. Kimura,T. Okamoto,H. Tamura.Comparison of 5- and 10-year survival rates in operated gastric cancer patients[J].Langenbecks Archiv für Chirurgie.1982(1)
  • 3Miwa H,Go MF,Sato N. H.pylori and gastric cancer: the Asian enigma[].The American journal of Gastroenterology.2002
  • 4Forman D,Newell DG,Fullerton F,Yarnell JW,Stacey AR,Wald N,Sitas F.Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from aprospective investigation[].British Medical Journal.1991
  • 5Parsonnet J,Harris RA,Hack HM,Owens DK.Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials[].The Lancet.1996
  • 6Roderick P,Davies R,Raftery J,Crabbe D,Pearce R,Patel P,Bhandari P.Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation[].Journal of Medical Screening.2003
  • 7Kang JY,Yeoh KG,Ho KY,Guan R,Lim TP,Quak SH,Wee A,Teo D,Ong YW.Racial differences in Helicobacter pylori seroprevalence in Singapore: correlation with differences in peptic ulcer frequency[].Journal of Gastroenterology.1997
  • 8Lee HS,Gwee KA,Teng LY,Kang JY,Yeoh KG,Wee A,Chua BC.Validation of [13C]urea breath test for Helicobacter pylori using a simple gas chromatograph-mass selective detector[].European Journal of Gastroenterology and Hepatology.1998
  • 9Briggs A,Sculpher M.An introduction to Markov modelling for economic evaluation[].Pharmacoeconomics.1998
  • 10Sonnenberg FA,Beck JR.Markov models in medical decision making: a practical guide[].Medical Decision Making.1993

共引文献2

同被引文献197

引证文献23

二级引证文献914

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部